Researchers are studying new methods that could improve the treatment of CML. Advances in cancer treatment and new ways to relieve side effects have resulted in increased quality of life and a better prognosis for many people with this disease.
Subjects discussed in this webinar:
- Latest developments in CML research and their implications for patient care and quality of life
- Targeted treatments biomarkers
- What the future holds
Dr. David Sanford, MD, FRCPC
Clinical Assistant Professor, Division of Hematology
Department of Medicine, University of British Columbia
View recording :
Offered in English, this presentation lasts 45 minutes with 15 minutes for Q&A.
This webcast was made possible thanks to the support of :
THE COLLINGS FAMILY FOUNDATION